8 U.S. lawmakers have disclosed 13 Elevance Health, Inc. trades under the STOCK Act — 9 buys and 4 sells between 2022 and 2026. Congress has been net buyers of ELV, and their disclosed buys are up 1.0% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of ELV, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed ELV buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-27 | Alan Armstrong | BUY | $1K–$15K | $286.39 | $398.22 2026-08-13 | +39.0% |
| 2025-12-29 | Markwayne Mullin | BUY | $15K–$50K | $348.38 | $398.22 2026-08-13 | +14.3% |
| 2025-03-10 | Jared Moskowitz | SELL | $1K–$15K | $409.55 | $398.22 2026-08-13 | +2.8% exit |
| 2024-04-10 | Dan Newhouse | BUY | $1K–$15K | $507.74 | $398.22 2026-08-13 | -21.6% |
| 2023-10-19 | Byron Donalds | BUY | $1K–$15K | $463.28 | $398.22 2026-08-13 | -14.0% |
| 2023-10-03 | Markwayne Mullin | BUY | $1K–$15K | $433.51 | $398.22 2026-08-13 | -8.1% |
| 2023-09-13 | Markwayne Mullin | BUY | $15K–$50K | $443.19 | $398.22 2026-08-13 | -10.2% |
| 2023-07-05 | Rick Larsen | SELL | $1K–$15K | $443.03 | $398.22 2026-08-13 | -6.8% rt |
| 2023-04-26 | John Curtis | BUY | $1K–$15K | $452.38 | $398.22 2026-08-13 | -12.0% |
| 2023-01-06 | Rick Larsen | BUY | $1K–$15K | $475.48 | $398.22 2026-08-13 | -16.3% |
| 2023-01-03 | Robert J. Wittman | SELL | $1K–$15K | $502.20 | $398.22 2026-08-13 | +20.7% exit |
| 2022-12-20 | John Curtis | SELL | $1K–$15K | $504.65 | $398.22 2026-08-13 | +21.1% exit |
| 2022-08-12 | Byron Donalds | BUY | $1K–$15K | $491.70 | $398.22 2026-08-13 | -19.0% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
8 members of the U.S. House and Senate have disclosed Elevance Health, Inc. transactions under the STOCK Act — 9 purchases and 4 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a ELV purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed ELV buys are up 1.0% versus the latest close of $398.22. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded ELV and how it performed.